Broadway Revival of ‘Glengarry Glen Ross’ Plays Final Performance January 20, 2013

GLENGARRY GLEN ROSS, which began previews on Friday, October 19, 2012, and officially opened on Saturday, December 8, 2012, will close this Sunday, January 20, 2013, at the Gerald Schoenfeld Theatre (236 West 45th Street). Upon closing, the production will have played 92 performances.

The cast is led by two-time Tony Award winner AL PACINO, who is joined by Tony nominee BOBBY CANNAVALE (The Motherf**ker with the Hat), Tony nominee DAVID HARBOUR (Edward Albee’s Who’s Afraid of Virginia Woolf?), Tony nominee JEREMY SHAMOS (Clybourne Park), Emmy Award winner RICHARD SCHIFF (“The West Wing”), JOHN C. McGINLEY (“Scrubs”) and MURPHY GUYER. Tony Award-winning director, DANIEL SULLIVAN (The Merchant of Venice, Proof) directs.

AL PACINO and BOBBY CANNAVALE are fierce and hilarious.
Time Out New York

“A CRACKLING REVIVAL OF DAVID MAMET’S foul-mouthed, BRILLIANTLY created and insightful look at men in the modern work place drenched in testosterone and verbal trickery.”
Associated Press

“It’s not every day that you get to see such top-notch performers play hardball onstage.”
USA Today

AL PACINO deserves a GREAT BIG HAND for his
DROP-DREAD-GORGEOUS turn as Shelly Levene.”
The Huffington Post

Tickets for all other performances are available for purchase at, by calling (212) 239-6200 or at the box office.

This production marks the 30th year anniversary of the play, which DAVID MAMET wrote in 1982. It premiered in the 1983-1984 season at the Royal National Theatre in London. That same year, it made its American debut at Chicago’s Goodman Theatre before moving to Broadway’s Golden Theatre where it ran for a total of 378 performances.

GLENGARRY GLEN ROSS has set design by Tony Award winner Eugene Lee (A Streetcar Named Desire, The Homecoming, Wicked), costume design by Tony Award winner Jess Goldstein (Newsies, The Rivals, The Merchant of Venice) and lighting design by James F. Ingalls (The People in the Picture, The Elephant Man, ‘night Mother).

Visit <> for more information.
Facebook: <>
Twitter: <>